Literature DB >> 19644962

European population substructure is associated with mucocutaneous manifestations and autoantibody production in systemic lupus erythematosus.

Sharon A Chung1, Chao Tian, Kimberly E Taylor, Annette T Lee, Ward A Ortmann, Geoffrey Hom, Robert R Graham, Joanne Nititham, Jennifer A Kelly, Jean Morrisey, Hui Wu, Hong Yin, Marta E Alarcón-Riquelme, Betty P Tsao, John B Harley, Patrick M Gaffney, Kathy L Moser, Susan Manzi, Michelle Petri, Peter K Gregersen, Carl D Langefeld, Timothy W Behrens, Michael F Seldin, Lindsey A Criswell.   

Abstract

OBJECTIVE: To determine whether genetic substructure in European-derived populations is associated with specific manifestations of systemic lupus erythematosus (SLE), including mucocutaneous phenotypes, autoantibody production, and renal disease.
METHODS: SLE patients of European descent (n=1,754) from 8 case collections were genotyped for >1,400 ancestry informative markers that define a north-south gradient of European substructure. Using the Structure program, each SLE patient was characterized in terms of percent Northern (versus percent Southern) European ancestry based on these genetic markers. Nonparametric methods, including tests for trend, were used to identify associations between Northern European ancestry and specific SLE manifestations.
RESULTS: In multivariate analyses, increasing levels of Northern European ancestry were significantly associated with photosensitivity (Ptrend=0.0021, odds ratio for highest quartile of Northern European ancestry versus lowest quartile [ORhigh-low] 1.64, 95% confidence interval [95% CI] 1.13-2.35) and discoid rash (Ptrend=0.014, ORhigh-low 1.93, 95% CI 0.98-3.83). In contrast, increasing levels of Northern European ancestry had a protective effect against the production of anticardiolipin autoantibodies (Ptrend=1.6x10(-4), ORhigh-low 0.46, 95% CI 0.30-0.69) and anti-double-stranded DNA autoantibodies (Ptrend=0.017, ORhigh-low 0.67, 95% CI 0.46-0.96).
CONCLUSION: This study demonstrates that specific SLE manifestations vary according to Northern versus Southern European ancestry. Thus, genetic ancestry may contribute to the clinical heterogeneity and variation in disease outcomes among SLE patients of European descent. Moreover, these results suggest that genetic studies of SLE subphenotypes will need to carefully address issues of population substructure based on genetic ancestry.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644962      PMCID: PMC2739103          DOI: 10.1002/art.24707

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  38 in total

1.  First presentation of systemic lupus erythematosus following ultraviolet radiation exposure in an artificial tanning device.

Authors:  O Fruchter; Y Edoute
Journal:  Rheumatology (Oxford)       Date:  2004-12-21       Impact factor: 7.580

2.  Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.

Authors:  Lindsey A Criswell; Kirsten A Pfeiffer; Raymond F Lum; Bonnie Gonzales; Jill Novitzke; Marlena Kern; Kathy L Moser; Ann B Begovich; Victoria E H Carlton; Wentian Li; Annette T Lee; Ward Ortmann; Timothy W Behrens; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2005-02-17       Impact factor: 11.025

3.  Clinical correlates, serum autoantibodies and the role of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with SLE.

Authors:  T A Podrebarac; D M Boisert; R Goldstein
Journal:  Lupus       Date:  1998       Impact factor: 2.911

4.  Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture.

Authors:  G S Alarcón; A W Friedman; K V Straaton; J M Moulds; J Lisse; H M Bastian; G McGwin; A A Bartolucci; J M Roseman; J D Reveille
Journal:  Lupus       Date:  1999       Impact factor: 2.911

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth.

Authors:  A E Johnson; C Gordon; R G Palmer; P A Bacon
Journal:  Arthritis Rheum       Date:  1995-04

7.  Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture.

Authors:  W C Knowler; R C Williams; D J Pettitt; A G Steinberg
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

8.  MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study. SLE Study Group.

Authors:  K Hartung; R Coldewey; A Corvetta; H Deicher; J R Kalden; F Krapf; B Lang; H J Lakomek; B Liedvogel; H H Peter
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

9.  Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences.

Authors:  M M Ward; S Studenski
Journal:  Arch Intern Med       Date:  1990-04

10.  Association of HLA-DM polymorphism with the production of antiphospholipid antibodies.

Authors:  M L Sanchez; K Katsumata; T Atsumi; F I Romero; M L Bertolaccini; A Funke; O Amengual; E Kondeatis; R W Vaughan; A Cox; G R V Hughes; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

View more
  15 in total

Review 1.  Using genetics to deliver personalized SLE therapy-a realistic prospect?

Authors:  Benjamin Rhodes; Timothy J Vyse
Journal:  Nat Rev Rheumatol       Date:  2010-05-04       Impact factor: 20.543

2.  Systemic lupus erythematosus diagnostics in the 'omics' era.

Authors:  Cristina Arriens; Chandra Mohan
Journal:  Int J Clin Rheumtol       Date:  2013-12-01

3.  Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population.

Authors:  Zaixing Yang; Yan Liang; Weiqiang Xi; Chang Li; Renqian Zhong
Journal:  Clin Exp Med       Date:  2010-10-21       Impact factor: 3.984

4.  European population substructure correlates with systemic lupus erythematosus endophenotypes in North Americans of European descent.

Authors:  I B Richman; S A Chung; K E Taylor; R Kosoy; C Tian; W A Ortmann; J Nititham; A T Lee; S Rutman; M Petri; S Manzi; T W Behrens; P K Gregersen; M F Seldin; L A Criswell
Journal:  Genes Immun       Date:  2009-10-22       Impact factor: 2.676

Review 5.  The genetics of human autoimmune disease: A perspective on progress in the field and future directions.

Authors:  Michael F Seldin
Journal:  J Autoimmun       Date:  2015-09-04       Impact factor: 7.094

6.  Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: a case-control study.

Authors:  Elisa Alonso-Perez; Marian Suarez-Gestal; Manuel Calaza; Gian Domenico Sebastiani; Rudolf Pullmann; Chryssa Papasteriades; Attila Kovacs; Fotini N Skopouli; Marc Bijl; Ana Suarez; Maurizio Marchini; Sergio Migliaresi; Patricia Carreira; Josep Ordi-Ros; Torsten Witte; Sarka Ruzickova; Maria Jose Santos; Nadia Barizzone; Francisco J Blanco; Bernard R Lauwerys; Juan J Gomez-Reino; Antonio Gonzalez
Journal:  Arthritis Res Ther       Date:  2012-04-27       Impact factor: 5.156

7.  Association of systemic lupus erythematosus clinical features with European population genetic substructure.

Authors:  Elisa Alonso-Perez; Marian Suarez-Gestal; Manuel Calaza; Torsten Witte; Chryssa Papasteriades; Maurizio Marchini; Sergio Migliaresi; Attila Kovacs; Josep Ordi-Ros; Marc Bijl; Maria Jose Santos; Sarka Ruzickova; Rudolf Pullmann; Patricia Carreira; Fotini N Skopouli; Sandra D'Alfonso; Gian Domenico Sebastiani; Ana Suarez; Francisco J Blanco; Juan J Gomez-Reino; Antonio Gonzalez
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

Review 8.  The Role of BANK1 in B Cell Signaling and Disease.

Authors:  Gonzalo Gómez Hernández; María Morell; Marta E Alarcón-Riquelme
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

9.  Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study.

Authors:  Elisa Alonso-Perez; Marian Suarez-Gestal; Manuel Calaza; Josep Ordi-Ros; Eva Balada; Marc Bijl; Chryssa Papasteriades; Patricia Carreira; Fotini N Skopouli; Torsten Witte; Emöke Endreffy; Maurizio Marchini; Sergio Migliaresi; Gian Domenico Sebastiani; Maria Jose Santos; Ana Suarez; Francisco J Blanco; Nadia Barizzone; Rudolf Pullmann; Sarka Ruzickova; Bernard R Lauwerys; Juan J Gomez-Reino; Antonio Gonzalez
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

Review 10.  Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis.

Authors:  Michael F Smith; Falk Hiepe; Thomas Dörner; Gerd Burmester
Journal:  Arthritis Res Ther       Date:  2009-11-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.